Rising Occurrence of CVDs and Obesity Boosts PTA Balloon Catheter Market

NEW YORK - May 2, 2024 - PRLog -- The PTA balloon catheter market was USD 2,231.6 million in 2022, which is likely to touch USD 4,591.2 million, propelling at a 9.4% compound annual growth rate, by 2030.

The growth of this industry is mainly because of the rising occurrence of obesity and CVDs, increasing tobacco consumption, and the surging count of minimally invasive surgical processes.

In 2022, the nylon category, based on material type, was the largest contributor to the industry. This is primarily because nylon catheters are scratch-resistant and have greater patient compliance.

The peripheral vascular disease category, on the basis of application, was the larger contributor to the industry, with more than 60% share, in 2022. In the U.S., the occurrence of peripheral vascular disease is between 45-50 million.

Moreover, the prevalence of the illness rises sharply with age, with over 20% of individuals over 80 years of age suffering from it.

In 2022, the standard and high-pressure PTA balloon catheters category, based on product type, accounted for the larger PTA balloon catheter market share, of more than 60%. Conventionally, this kind of balloon was employed in angioplasty, however, its applications in different diagnostic and therapeutic processes have surged due to the advancement in the fabrication technology, design, and material of the balloon.

Moreover, these enhancements provide greater lengths, ultra-thin walls for a tinier minimal invasion and profile, improved diameters, varying diameters in the balloon, specialty coatings, tapered ends & angles, and custom shapes.

Report Description: https://www.psmarketresearch.com/market-analysis/pta-ball...

The requirement for PTA balloon catheters is rising in hospitals because of the increasing occurrence of CVDs as well as the rising count of patients visiting hospitals.

Moreover, the accessibility of experienced healthcare providers, the rising count of cardiac specialty hospitals, the increasing medical tourism sector, and a large pool of patients are also boosting category growth.

North America was the largest contributor to the industry in 2022, with approximately 35% share. For many years, CVDs have been a key cause of mortality in the U.S. According to the CDC, in 2021, 0.69 million individuals in the U.S. died of heart ailments, with over one demise each minute.

APAC is advancing at the fastest rate, primarily due to the surging occurrence of problems associated with the heart as well as the mounting elderly populace. Moreover, the most common heart ailments in India are coronary artery disease, cardiomyopathy, rheumatic heart disease, cerebrovascular disease, valvular heart disease, heart failure, and heart attack.

SOURCE: P&S Intelligence